Stoney Creek firm licenses stem cell technology
New York-based IntelliCell BioSciences has licensed its patent-pending technology for the manufacture of stem cells to RegenaStem Inc., based in Stoney Creek. Under the agreement, the company name, RegenaStem, will be changed to IntelliCell BioSciences of Canada. According to company president, Jason Kane, talks are under way with Health Canada to begin manufacturing stem cells and using the technology to treat people with degenerative joint disease, such as arthritis. The treatment is designed to rebuild and repair cartilage and tissue. Clinical trials are set to begin this year. Other applications are also being planned.
Kane’s background in stem cell work includes leading the launch of the first in-clinic stem cell therapy kits for veterinarians in Canada. For more information, call 289-887-5195 or emailjkane@intellicellbiosciences.ca
No comments:
Post a Comment